Candicidin
From Wikipedia, the free encyclopedia
 |
|
|
Candicidin
|
|
| Systematic (IUPAC) name | |
| 33-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl]-1,3,5,7,37-pentahydroxy-18-methyl-9,13,15-trioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | G01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C59H84N2O18 |
| Mol. mass | 875.9947 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Candicidin is an antibiotic.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||
